Advertisement
UK markets closed
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • CRUDE OIL

    83.34
    +1.44 (+1.76%)
     
  • GOLD FUTURES

    2,336.10
    -10.30 (-0.44%)
     
  • DOW

    38,507.64
    +267.66 (+0.70%)
     
  • Bitcoin GBP

    53,395.84
    +55.88 (+0.10%)
     
  • CMC Crypto 200

    1,431.70
    +16.94 (+1.20%)
     
  • NASDAQ Composite

    15,692.43
    +241.13 (+1.56%)
     
  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     

New Strong Buy Stocks for April 8th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

M.D.C. Holdings, Inc. (MDC): This company that is engaged in homebuilding and financial service businesses in the United States has seen the Zacks Consensus Estimate for its current year earnings increasing 7.7% over the last 60 days.

M.D.C. Holdings, Inc. Price and Consensus

M.D.C. Holdings, Inc. Price and Consensus
M.D.C. Holdings, Inc. Price and Consensus

M.D.C. Holdings, Inc. price-consensus-chart | M.D.C. Holdings, Inc. Quote

Nutrien Ltd. (NTR): This producer and seller of fertilizers and related industrial and feed products has seen the Zacks Consensus Estimate for its current year earnings increasing 19.4% over the last 60 days.

Nutrien Ltd. Price and Consensus

Nutrien Ltd. Price and Consensus
Nutrien Ltd. Price and Consensus

Nutrien Ltd. price-consensus-chart | Nutrien Ltd. Quote

ADVERTISEMENT

LeMaitre Vascular, Inc. (LMAT): This provider of devices, implants and services for the treatment of peripheral vascular disease has seen the Zacks Consensus Estimate for its current year earnings increasing 7.6% over the last 60 days.

LeMaitre Vascular, Inc. Price and Consensus

LeMaitre Vascular, Inc. Price and Consensus
LeMaitre Vascular, Inc. Price and Consensus

LeMaitre Vascular, Inc. price-consensus-chart | LeMaitre Vascular, Inc. Quote

Capstar Financial Holdings, Inc. (CSTR): This bank holding company for CapStar Bank has seen the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.

Capstar Financial Holdings Inc. Price and Consensus

Capstar Financial Holdings Inc. Price and Consensus
Capstar Financial Holdings Inc. Price and Consensus

Capstar Financial Holdings Inc. price-consensus-chart | Capstar Financial Holdings Inc. Quote

MYR Group Inc. (MYRG): This holding company of leading specialty contractors serving the electrical infrastructure market throughout the United States and Canada has seen the Zacks Consensus Estimate for its current year earnings increasing 5.3% over the last 60 days.

MYR Group, Inc. Price and Consensus

MYR Group, Inc. Price and Consensus
MYR Group, Inc. Price and Consensus

MYR Group, Inc. price-consensus-chart | MYR Group, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Time to Invest in Legal Marijuana

If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.

After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%

You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.

Today, Download Marijuana Moneymakers FREE >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Nutrien Ltd. (NTR) : Free Stock Analysis Report

MYR Group, Inc. (MYRG) : Free Stock Analysis Report

M.D.C. Holdings, Inc. (MDC) : Free Stock Analysis Report

LeMaitre Vascular, Inc. (LMAT) : Free Stock Analysis Report

Capstar Financial Holdings Inc. (CSTR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research